- Sorted by date
- Hybrid Sort
- Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: cancer, cancer patients, cancer risk, lung cancer, prostate cancer
Results 51 to 60 of 68 
Adherex posts wider 3Q loss on increased expenses
Cancer drug company Adherex Technologies Inc. said Monday that its third quarter loss
widened in 2006 because of higher operating expenses tied to ongoing clinical trials … 
- ├ Kitty Hawk posts wider 3Q loss — bizjournals.com Travel:Airlines & Airports headlines …
- ├ Regency posts larger 3Q loss — Latest news from Dallas Business Journal
- ├ UGS Corp. posts wider 3Q loss — Latest news from Dallas Business Journal
- └ all 10 related »
NICE refuses to fund life-prolonging cancer drug available in Scotland
NICE has refused to fund a lung cancer drug which prolongs life even though it is
already available in Scotland. The health watchdog's decision will stoke controversy over
access to …
- ├ NICE refuses to fund £20,000 cancer drug … — the Mail online | Home
- ├ NICE refuse to fund life-prolonging cancer drug … — the Mail online | Health
- ├ Cancer drug guidance concern — BBC News | Health | UK Edition
- └ all 10 related »
NICE disapproves the use of cancer drug Tarceva
… cancer, has caused an uproar among the cancer specialists and thousands of
lung cancer patients all over England …
- ├ NICE rejects use of cancer drug Tarceva — Pharmaceutical Business Review Latest News
- ├ NICE consults on advice on two treatments … — OnMedica Latest News
- ├ Watchdog rules against new treatment for lung … — Guardian Unlimited UK Latest
- └ all 10 related »
Dendreon Asks FDA to OK Prostate Drug
Cancer-treatment developer Dendreon said it submitted the final portion of a
biologics license application to the FDA …
- ├ Dendreon completes FDA filing for prostate-cancer drug … — The Seattle Times: Horse racing
- ├ Dendreon Completes Submission of Biologics License Application … — Government/ Industry Regulation News from StratCenter.com …
- ├ Dendreon seeks OK for Provenge — United Press International - Health Business
- └ all 10 related »
Dendreon completes FDA filing for prostate-cancer drug
Dendreon said Monday it has submitted the final portion of its application to the Food and
Drug Administration for approval to market its prostate cancer drug in the U.S …
- ├ Aeterna prostate cancer drug shows promise — Pharmaceutical Business Review Latest News
- ├ Prostate-specific symptoms of prostate cancer in a … — Prostate Cancer and Prostatic Diseases
- ├ Bicalutamide (Casodex) 150 mg plus standard care … — Prostate Cancer and Prostatic Diseases
- └ all 10 related »
Single-Dose Drug-Loaded Dendrimer Cures Mice of Colon Cancer
… drug delivery vehicle that when loaded with a widely used anticancer agent cures
colon cancer in mice with a single dose …
- ├ Anti-Cancer Tinker Toys — Responsible Nanotechnology
- ├ Risk after colon cancer higher for the … — EurekAlert! - Breaking News
- ├ Very fat/very thin at high colon-cancer risk — United Press International - Health Business
- └ all 10 related »
Tailored treatments: Promising designer drug provides new insight into cancer …
… cancer progression and treatment resistance. Two studies in the November 2006
issue of the journal Cancer Cell, published by Cell Press, provide mechanistic
details that may explain why the small-molecule …
- ├ Designer drug to blame for disintegrating euro … — News
- ├ Recurrent breast cancer: Drug shows promise — The Cancer Blog
- ├ Exercise, aspirin consumption and childbirth may alter … — EurekAlert! - Biology
- └ all 10 related »
Drug That Interrupts A Key Stage Of Cell Division Shows …
One of the first studies to investigate the effects of a new anti-cancer drug in
patients with advanced or metastatic solid tumours has shown that it is capable of halting …
- ├ Drug That Interrupts A Key Stage Of … — Health News from Medical News Today
- ├ Enzyme Inhibitor Produces Stable Disease In Patients … — Health News from Medical News Today
- ├ Enzyme Inhibitor Produces Stable Disease In Patients … — Health News from Medical News Today
- └ all 10 related »
UCSD computer scientist wins Young Investigator Award, research on snake …
… drug development efforts, help scientists better understand cancer proteins
and, perhaps, let scientists dive into dinosaur genetics …
- ├ Medical Mutual of OH Financial Investigator Wins … — StratWire - Business of Healthcare NewsFeed
- ├ GSA confers 2006 Nathan Shock New Investigator … — EurekAlert! - Medicine and Health
- ├ Rensselaer scientist honored for carbon nanotube research … — EurekAlert! - Technology, Engineering and Computer Science …
- └ all 10 related »
Cancer drug guidance dismay
Campaigners express dismay that a lung cancer drug available in Scotland may not be
approved for England …
- ├ Dismay over cancer drug guidance — BBC News | Latest Published Stories | UK Edition
- ├ SUPPLEMENTAL GUIDANCE FOR ASSESSING SUSCEPTIBILITY FROM EARLY-LIFE … — Recent EPA Catalog Records.
- ├ 2005 CANCER GUIDELINES AND EARLY-LIFE SUPPLEMENTAL GUIDANCE … — Recent EPA Catalog Records.
- └ all 10 related »